These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17445163)

  • 21. Partially matched related hematopoietic stem cell transplantation without ex vivo T cell depletion compared with matched unrelated transplantation in adult patients with hematologic malignancies.
    Wang Y; Chen F; Han Y; Fu ZZ; Tang XW; Miao M; Qiu HY; Jin ZM; Sun AN; Wu DP
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1258-64. PubMed ID: 19747633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation.
    Heemskerk MB; Cornelissen JJ; Roelen DL; van Rood JJ; Claas FH; Doxiadis II; Oudshoorn M
    Bone Marrow Transplant; 2007 Aug; 40(3):193-200. PubMed ID: 17529995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of vitamin D receptor polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation.
    Bogunia-Kubik K; Middleton P; Norden J; Dickinson A; Lange A
    Int J Immunogenet; 2008 Jun; 35(3):207-13. PubMed ID: 18312595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GvHD and complications following related and unrelated donor haematopoietic stem cell transplantation.
    Holler E; Rogler G; Brenmoehl J; Hahn J; Greinix H; Dickinson AM; Socie G; Wolff D; Finke J; Fischer G; Jackson G; Rocha V; Hilgendorf I; Eissner G; Marienhagen J; Andreesen R
    Int J Immunogenet; 2008 Aug; 35(4-5):381-4. PubMed ID: 18976442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Killer-cell immunoglobulin-like receptor ligand compatibility in the outcome of Finnish unrelated donor hematopoietic stem cell transplantation.
    Sivula J; Volin L; Porkka K; Vettenranta K; Itälä M; Partanen J; Turpeinen H
    Transpl Immunol; 2007 Jul; 18(1):62-6. PubMed ID: 17584604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation.
    Orti G; Lowdell M; Fielding A; Samuel E; Pang K; Kottaridis P; Morris E; Thomson K; Peggs K; Mackinnon S; Chakraverty R
    Transplantation; 2009 Dec; 88(11):1312-8. PubMed ID: 19996931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.
    Loiseau P; Busson M; Balere ML; Dormoy A; Bignon JD; Gagne K; Gebuhrer L; Dubois V; Jollet I; Bois M; Perrier P; Masson D; Moine A; Absi L; Reviron D; Lepage V; Tamouza R; Toubert A; Marry E; Chir Z; Jouet JP; Blaise D; Charron D; Raffoux C
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):965-74. PubMed ID: 17640601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical implications of HLA mismatches in unrelated donor haematopoietic cell transplantation.
    Shaw BE
    Int J Immunogenet; 2008 Aug; 35(4-5):367-74. PubMed ID: 18976440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.
    Fuji S; Kim SW; Fukuda T; Mori S; Yamasaki S; Morita-Hoshi Y; Ohara-Waki F; Heike Y; Tobinai K; Tanosaki R; Takaue Y
    Biol Blood Marrow Transplant; 2008 May; 14(5):510-7. PubMed ID: 18410893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
    Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
    Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenic disparities of 11 minor histocompatibility antigens (mHAs) in HLA-matched unrelated allogeneic hematopoietic SCT.
    Markiewicz M; Siekiera U; Karolczyk A; Szymszal J; Helbig G; Wojnar J; Dzierzak-Mietla M; Kyrcz-Krzemien S
    Bone Marrow Transplant; 2009 Feb; 43(4):293-300. PubMed ID: 18850018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indications and donor selections for allogeneic stem cell transplantation in children with hematologic malignancies.
    Handgretinger R; Kurtzberg J; Egeler RM
    Pediatr Clin North Am; 2008 Feb; 55(1):71-96, x. PubMed ID: 18242316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation.
    Danzer M; Polin H; Pröll J; Haunschmid R; Hofer K; Stabentheiner S; Hackl C; Kasparu H; König J; Hauser H; Binder M; Weiss R; Gabriel C; Krieger O
    Transplantation; 2009 Aug; 88(4):528-32. PubMed ID: 19696636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low serum levels of total rabbit-IgG is associated with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation: results from a prospective study.
    Remberger M; Sundberg B
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):996-9. PubMed ID: 19589490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.
    Wu J; Tang JL; Wu SJ; Lio HY; Yang YC
    Clin Chim Acta; 2009 May; 403(1-2):229-33. PubMed ID: 19332044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth.
    Soncini E; Slatter MA; Jones LB; Hughes S; Hodges S; Flood TJ; Barge D; Spickett GP; Jackson GH; Collin MP; Abinun M; Cant AJ; Gennery AR
    Br J Haematol; 2009 Apr; 145(1):73-83. PubMed ID: 19222467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study.
    Remberger M; Mattsson J; Hassan Z; Karlsson N; LeBlanc K; Omazic B; Okas M; Sairafi D; Ringdén O
    Bone Marrow Transplant; 2008 Feb; 41(4):399-405. PubMed ID: 17982493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
    Lanino E; Rondelli R; Locatelli F; Messina C; Pession A; Balduzzi A; Favre C; Santarone S; Rabusin M; Pollichieni S; Cesaro S; Dini G;
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):741-8. PubMed ID: 19450759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.